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Abstract
Background: Older adults hospitalized with fragility fractures are at high risk of negative events that can culminate
in re-presentations to hospital emergency departments or readmissions to hospital. This systematic review aimed to
identify patient, clinical, or hospital-related factors that are identifiable at the index admission and that may be
associated with re-presentations to hospital emergency departments or hospital readmissions in older adults
following fragility fractures.
Methods: Four electronic databases (PubMed, CINAHL, Embase, and Scopus) were searched. A suite of search terms
identified peer-reviewed English-language articles that examined potential correlates of hospital re-presentation in
older adults (mean age ≥ 65 years) who were discharged from hospital following treatment for fragility fractures. A
three-stage screening process (titles, abstracts, full text) was conducted by two researchers independently. Participant
characteristics, study design, potential correlates examined, analyses, and findings were extracted for studies included in
the review. Quality and risk of bias were assessed with the Effective Public Health Practice Project Quality Assessment
Tool. The strength of evidence was incorporated into a best evidence synthesis, and meta-analysis was conducted
where effect pooling was possible.
Results: Eleven of 35 eligible studies were categorized as high quality studies. These studies reported that age, higher
Cumulative Illness Rating scores, American Society of Anesthesiologists scores > 3, longer length of stay, male sex,
cardiovascular disease, low post-operative hemoglobin, kidney disease, dementia and cancer were factors
identified at the index admission that were predictive of subsequent re-presentation to hospital. Age was the only
predictor for which pooling of effects across studies was possible: pooling was conducted for re-presentation≤ 30 days
(pooled OR, 1.27; 95 % CI, 1.14–1.43) and > 30 days (pooled OR, 1.23; 95 % CI, 1.01–1.50).
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Conclusions: The best-evidence synthesis, in addition to the meta-analysis, identified a range of factors that may have
utility in guiding clinical practice and policy guidelines for targeted interventions to reduce the need for re-presentation
to hospital among this frail clinical population. The paucity of studies investigating re-presentations to hospital
emergency departments without admission was an important gap in the literature identified in this review. Key
limitations were exclusion of non-English language studies and grey literature.
Systematic review registration: PROSPERO CRD42015019379.
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Background
The incidence of fragility fractures is expected to rise as the
population of older adults increases [1, 2]. Fragility fractures
are fractures sustained from relatively minor forces (e.g., fall
from standing height or less) and often occur among people
with osteoporosis [3]. Negative outcomes associated with
these fractures include disability, morbidity, hospitalization,
and increased risk of premature death following the frac-
ture event [4]. These unfavorable outcomes burden patients
and increase demand on healthcare services [5, 6].
During an index presentation to hospital after a fragility
fracture, the fracture will be examined, and unstable frac-
tures will typically be stabilized using either surgical or non-
surgical approaches [7]. Following acute management of the
fracture and potentially inpatient rehabilitation, patients are
discharged from hospital. However, a re-presentation to
hospital may be required soon after discharge [8].
Although there is inconsistency regarding time-frames
between studies investigating hospital re-presentations,
these may typically be considered to include subsequent
unplanned visits to a hospital sometime within the first
2 years following hospitalization [9]. They include emer-
gency department (ED) visits without hospital admission,
same-day discharges, and inpatient admissions for 1 or
more days. Most older adults returning to hospital within
1 month re-present with a clinical problem or diagnosis
related to their index admission, and this is a relatively fre-
quent occurrence among older adults [10].
For those seeking to decrease re-presentation rates after
treatment for fragility fractures, it is advantageous to
understand the factors that predict re-presentations. To
date, no systematic review has examined the range of re-
ported risk factors for hospital re-presentation among
older adults following hospitalization for fragility fracture
management. One systematic review examined the timing
of surgery on negative outcomes following hip fractures
[11]. The authors concluded that surgery within 48 hours
of hospital admission for a hip fracture reduced the length
of hospital stay, mortality rates, and complications. They
also concluded that surgical delays increased the risk of
complications. Another review examined the outcomes of
patients with osteoporotic fractures after hospital dis-
charge [12]. Those patients were reported to be at high
risk of morbidity, mortality, and subsequent fracture. An-
other systematic review summarized the risk factors for
hospital readmissions in non-fracture-specific samples
and reported that functional disability and comorbidi-
ties were correlated with readmission to hospital [13].
Research findings summarized in the aforementioned
reviews provide some understanding of the risk of nega-
tive outcomes after hospital discharge that may have
relevance to people recovering from fragility fractures.
However, people recovering from fragility fractures may
not have the same risk profile as those who are less frail
or admitted to hospital for other health conditions.
Therefore, the aim of the present study was to examine
potential correlates of hospital re-presentation following
fragility fractures in older adults. Specifically, the review
focused on reports of patient-, clinical-, or hospital-
related factors that could be identified at the time of the
initial hospitalization, and re-presentation time-frames
of up to 2 years after the initial hospitalization.
Methods
Design
The protocol for this systematic review and meta-analysis
has previously been reported and is summarized below [14].
Data sources and searches
Databases were searched for articles in peer-reviewed,
English-language journals from the onset of the data-
bases until August 24, 2015. The literature was searched
in phases. First, a comprehensive list of terms and syno-
nyms of re-presentations, fracture, elderly, and hospital
were combined with Boolean operators to formulate a
search string. Second, a systematic search was conducted
using the search string to identify relevant studies in
four electronic databases: EMBASE, PubMed/Medline,
Scopus, and CINAHL via the EBSCO interface. The
search strings adapted for each database are presented
in Table 1. Finally, the reference lists of included articles
were searched for additional relevant studies. Studies
identified through reference lists were initially assessed
for relevance by study title and abstract. The results
were imported into reference management software
(Endnote) to manage, extract data and delete duplicate
references.
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Study selection
The selection of articles consisted of three stages of
screening (titles, abstracts, full text), which were con-
ducted by SAM and EG independently of each other. A
third author (SMM) arbitrated any unresolved disagree-
ments arising during any stage in the search and screening
process. Further details about the search and selection
strategy were outlined in the protocol [14].
Types of studies Quantitative studies that explored the
correlates of hospital re-presentations in older adults for
any time-frame within the first 2 years were eligible for
inclusion. Both epidemiological (retrospective and pro-
spective cohort studies) and experimental study designs
(that also reported risk factors from analyses of participat-
ing cohorts) were eligible for inclusion. Cohort studies were
classified as retrospective if the hospital re-presentations
had already occurred at the time of study planning and
historical cases or events were being audited. In contrast,
cohort studies were classified as prospective if study plan-
ning occurred prior to the study enrolment period in
which hospital re-presentations were observed. Qualitative
studies and grey literature were excluded. Authors of in-
cluded studies were contacted for further information.
Types of participants Only studies that recruited older
adults (mean age ≥ 65 years) who were hospitalized fol-
lowing fragility fractures were included. There were no
sex, race, ethnicity, residential status (residential care facil-
ities, or elsewhere in the community), or socioeconomic
status restrictions for participants.
Types of outcomes Studies that examined hospital re-
presentation as an outcome were included. Studies that
examined correlates of re-presentations in a general pa-
tient population but reported separate analyses for re-
presentations in older adults with fragility fractures were
eligible for inclusion. Outcomes of secondary interest
were the number and frequency of re-presentations, the
rate of re-presentations, and days since discharge to re-
presentation.
Data extraction and quality assessment
Two reviewers conducted the data extraction and quality
assessment independently (SAM and EG). A third re-
viewer (SMM) arbitrated unresolved disagreements. The
data extracted included details about the participant
characteristics, study design, inclusion and exclusion cri-
teria, risk factors, primary outcomes (re-presentations),
and statistical analysis. The quality of individual studies
and risk of bias were assessed with the Effective Public
Health Practice Project Quality Assessment Tool [15, 16].
This quality assessment tool can be widely used to rate the
methodological parameters across all quantitative study
designs. A best-evidence synthesis was implemented to in-
tegrate the strength of evidence of studies [17].
Data synthesis and analysis
Substantial methodological, statistical, and quality of
reporting heterogeneity present in the studies was con-
sidered by the investigators to prohibit the valid pooling
of effects (meta-analysis) for all potential predictors ex-
cept age. Age was the only factor for which the defin-
ition and method of reporting results were somewhat
similar across a pool of studies. Hence, the extracted
study characteristics and results from all eligible studies
were tabulated and summarized in a best evidence
synthesis, and a meta-analysis was performed to obtain
pooled estimates for age for re-presentations within
30 days and re-presentations after 30 days using RevMan
(version 5.1, Cochrane Collaboration).
For the meta-analysis, odds ratios (ORs) were not able
to be directly obtained in a consistent and easily inter-
pretable format (e.g., estimates of effect per increasing
year of age) due to differences in statistical analyses and
reporting among studies that included age as a potential
correlate of hospital re-presentation. To obtain ORs
from each study, the following strategy was used. First,
effect sizes (ORs, relative risks or hazard ratios) were ex-
tracted or calculated from original studies where pos-
sible. Because some studies reported effect sizes for age
separately for different subgroups, the effect sizes for
these groups were merged via inverse variance pooling
before entering them into the meta-analysis. If ORs and
confidence intervals (CI) were reported, these were
Table 1 Search syntaxes customized for each database
Database Search syntax
PubMed (fracture[MeSH Terms]) AND (((readmi* or rehosp* or re-admi* or re-hosp* or re-presentation)) OR “Patient Readmission”[MeSH])
Filters: Aged: 65+ years
CINAHL “fracture* AND (readmi* or rehosp* or re-admi* or re-hosp* or re-presentation) Age Groups: Aged: 65+ year
Embase “fracture”/exp and (readmi* or rehosp* or re-admission or re-hospitalisation or re-hospitalization or re-presentation) AND
([aged]/lim OR [very elderly]/lim)
Scopus ABS fracture* AND (readmi* OR rehosp* OR re-admission OR re-hospitalisation OR re-hospitalization or re-presentation) AND
(aged OR elderly OR geriatric OR old*)
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taken directly from the studies. If ORs were reported
separately for different re-presentation time periods
within a study, the results were combined (with meta-
clustering) to give one estimate for re-presentation within
30 days, and one estimate for re-presentation after 30 days
[18]. If relative risks were reported, prevalence of the risk
factors and incidence of hospital re-presentations were
used to calculate ORs from available data. Rate ratios and
standardized mean differences were extracted and calcu-
lated from P values to calculate ORs, where relevant. The
random effects model of analysis was used to best account
for heterogeneity, and tests of heterogeneity (I2) were per-
formed. A sensitivity analysis was performed to examine
the effect of removing one small study [19] with an age ef-
fect estimate for re-presentation within 30 days that fell
outside the confidence ranges of any other included
studies (OR estimate was considerably higher).
Results
The outcome of the study identification and selection
process is outlined in Fig. 1. In summary, after the re-
moval of 339 duplicates, a total of 430 unique studies were
identified across four databases. Eighty-eight articles were
deemed eligible for full text screening, of which 53 studies
were excluded for not meeting the inclusion criteria. The
remaining 35 studies were included in this review.
Study characteristics
The characteristics of the included studies are described
in Table 2. The review included one randomized con-
trolled trial that reported the effect of cholecalciferol
and physiotherapy on hospital readmissions, but also re-
ported correlates of re-presentation [20]. The remaining
34 studies were retrospective cohort studies (n = 23),
prospective cohort studies (n = 9), an interrupted time
series study (n = 1) [21], or a combination of retrospective
and prospective cohort designs (n = 1) [22]. Despite the
delineation between retrospective and prospective cohort
studies in this review, it is perhaps noteworthy that both
types typically used information sources recorded at (or at
least near) the time of the events of interest (e.g., in pa-
tient medical records). Subsequently, the authors of this
review did not consider there to be a substantial difference
in interpretation of the reliability of data originating from
the included retrospective and prospective studies. All
studies addressed risk factors for hospital readmissions;
none addressed risk factors for hospital re-presentations
more broadly, which could have included ED presenta-
tions without admission to hospital. Therefore, below,
only factors associated with readmissions are presented.
Approximately half of the studies (n = 19, 54 %) were
from the United States, with the remainder conducted
in France (n = 2), Singapore (n = 2), Taiwan (n = 2), or
Fig. 1 Study selection flow diagram
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Table 2 Characteristics of studies included in the systematic review
Author and year of
publication
Country Site Study design Sample characteristics Sample size/
population
Study time
period
Fracture
site
Basques et al. (2015) [30] USA 370 hospitals Retrospective
cohort
>70 years 8434 2011–2012 Hip
Bischoff-Ferrari et al. (2010) [20] Switzerland Single hospital Randomized
controlled trial
≥65 years 173 2005–2007 Hip
Boddaert et al. (2014) [21] France Single hospital Interrupted time
series
≥70 years 334 2005–2012 Hip
Fox et al. (1998) [31] USA 8 hospitals Prospective cohort ≥65 years 306 1990–1991 Hip
French et al. (2008) [25] USA Veterans Health
Administration
Medical Centre
Retrospective
cohort
≥65 years 41,331 1999–2003 Hip
Giusti et al. (2008) [32] Italy Single hospital Prospective cohort ≥70 years 236 2000–2001 Hip
Golinvaux et al. (2014) [48] USA 350 hospitals Retrospective
cohort
≥65 years 9938 2005–2012 Hip
Gregersen et al. (2011) [42] Denmark Single hospital Prospective cohort ≥65 years (Nursing
Home Residents)
233 2006–
2010.
Hip
Hageman et al. (2014) [43] USA Level 1 trauma
center
Retrospective
cohort
Mean age > 65 890 2008–2011 Hip
Halm et al. (2003) [27] USA 4 hospitals Prospective cohort Mean age > 65 559 1997–1998 Hip
Halm et al. (2003) [33] USA 4 hospitals Prospective cohort Mean age > 65 551 1997–1998 Hip
Halm et al. (2004) [34] USA 4 hospitals Prospective cohort Mean age > 65 550 1997–1998 Hip
Härstedt et al. (2015) [35] Sweden Single hospital Prospective cohort Mean age > 65 272 2009–2011 Hip
Heidari et al. (2012) [26] UK 62 hospital
pharmacies
Retrospective
cohort
Mean age > 65 255,841 2003–2007 Hip
Heyes et al. (2015) [29] Ireland Single hospital Prospective cohort Mean age > 65 451 2010–2012 Hip
Hsaio et al. (2011) [23] Taiwan Health insurance
database
Retrospective
cohort
Mean age > 65
(women)
11,278 2001–2007 Hip/
Vertebra
Intrator and. Berg (1998) [44] USA Medicare
beneficiaries
Retrospective
cohort
≥70 years 324 1987–1991 Hip
Jou et al. (2014) [24] Taiwan Health insurance
database
Retrospective
cohort
Mean age > 65
(women)
9467 2003–2006 Hip
Kates et al. (2014) [28] USA Level 3 trauma
center
Retrospective
cohort
≥65 years 1081 2005–2010 Hip
Kates et al. (2015) [49] USA Level 3 trauma
center
Retrospective
cohort
≥65 years 1081 2005–2010 Hip
Khan et al. (2012) [36] UK Single hospital Retrospective
cohort
Mean age > 65 467 2009–2010 Hip
Kiel et al. (1994) [45] USA 43 nursing
homes
Prospective cohort Mean age > 65 2624 1984–1988 Hip
Le-Wendling et al. (2012) [37] USA Single hospital Retrospective
cohort
≥65 years 308 2006–2008 Hip
Ling et al. (2013) [19] Singapore Single hospital Retrospective
cohort
Mean age > 65 254 2009–2010 Hip
Merchant et al. (2005) [38] Singapore Single hospital Retrospective
cohort
Mean age > 65 180 2001–2001 Hip
Ottenbacher et al. (2003) [46] USA 171 hospitals Retrospective
cohort
Mean age > 65 9956 1994–1998 Hip
Pollock et al. (2015) [50] USA Level 1 trauma
center
Retrospective
cohort
Mean age > 65 1482 2005–2012 Hip
Radcliff et al. (2008) [51] USA Veterans Health
Administration
Medical Center
Retrospective
cohort
Mean age > 65 5683 1998–2003 Hip
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elsewhere (n = 9). Sixteen studies (46 %) specifically tar-
geted patients aged ≥ 65 years, although all reported a
mean age > 65 years. Two studies included women only
[23, 24]. One study restricted the analyses to nursing
home residents [25].
The sample size of studies ranged from 173 patients
[20] to 255,841 patients [26]. There were two kin studies
that investigated different risk factors from the same
large dataset [27, 28]. The total length of the enrollment
period for the studies ranged from ≤ 2 years for 15 stud-
ies [27, 29–41], 3–5 years for eight studies [20, 22, 24–
26, 42–47], 6–8 years for eight studies [21, 23, 28, 30,
48–52], and up to 10 years for one study [53]. This re-
view focused on findings reported for re-presentations
within the first 2 years after the index hospital event.
Specifically, the observed timeframe for hospital re-
presentations for findings reported in this review ex-
tended from 7 days to 18 months after the index hospital
event [24, 31]. Hip fracture was the most common frac-
ture site (n = 32 studies) [20–40, 42–46, 48–51, 53]. Two
studies examined patients with vertebral fractures, and
one study examined patients with proximal humerus
fractures [41, 47, 52].
Risk factors associated with re-presentations
The risk factors for hospital re-presentations that were
examined are listed in Table 3 by shortest to longest ob-
servation time-frame after the index event in which re-
presentation may have occurred. Most studies examined
correlates of readmission within 30 days of the index
event (i.e., 30 days since the initial hospital discharge
(n = 8), an operation (n = 6), or admission to a nursing
home (n = 1)). Other studies examined correlates within
60 days (n = 3), 90 days (n = 3), 6 months (n = 2), and
1 year (n = 7) from the index event. Two studies used
multiple follow-up periods [24, 47]. For the purpose of
this synthesis, correlates were categorized into patient
characteristics and other clinical or hospital indicators.
Patient characteristics
Patient characteristics that were investigated as possible
risk factors were age, gender, physical function, and level
of independence with daily living. Seven of the 14 stud-
ies that investigated age reported a significant positive
association [19, 21, 24, 28, 30, 36, 49]. Six studies exam-
ined the effect of male sex on subsequent hospital re-
admission, and three found male sex to be a risk factor
of readmission [25, 30, 40]. Two studies reported being
aged > 75 years and receiving treatment from a regional
hospital for the index hospital event as predictors of
hospital readmissions at 14 days, 30 days, and 1 year
after the index event [24, 47]. A study that examined
predictors of hospital readmissions within 1 year of dis-
charge identified male gender and increasing age as risk
factors of hospital readmissions [40]. Four out of five
studies that examined the Cumulative Illness Rating
Score (CIRS) identified that a CIRS score > 2 was predict-
ive of hospital readmission [21, 24, 28, 32]. Five studies
that investigated residential status of patients after the
index hospital event found a positive correlation between
discharge to a nursing home and 30-day risk of hospital
readmission [29, 30, 36, 45, 50].
Physical and mental health comorbidities were also ex-
amined as potential risk factors for readmissions; there
was, however, a considerable variation in the comorbidi-
ties investigated. Eight studies examined the association
between cardiovascular disease and hospital readmission:
five of the studies found a positive association [25, 28,
30, 49, 50]. Eight studies examined the association be-
tween diabetes and readmission. Three of these studies
reported a significant positive association [25, 36, 49],
but two that only included surgical cases did not find an
association. Two of the five studies that investigated
renal insufficiencies and kidney diseases as predictors of
readmission reported significant positive associations
[25, 51]. One of the three studies that examined post-
surgical anemia and one of the four studies that specifically
Table 2 Characteristics of studies included in the systematic review (Continued)
Riggs et al. (2010) [39] USA Single hospital Retrospective
cohort
≥65 years 606 2004–2006 Hip
Teixeira et al. (2009) [40] France Single hospital Retrospective
cohort
≥70 years 5709 2005–2006 Hip
Toson et al. (2015) [53] Australia 247 hospitals Retrospective
cohort
Mean age > 65 47,698 2001–2010 Hip
Toy et al.(2014) [41] USA 370 hospitals Retrospective
cohort
≥65 years 850 2011–2012 Vertebra
Tsai et al. (2013) [47] Taiwan National Health
Insurance
Retrospective
cohort
≥70 years 9238 2004–2007 Vertebra
Vochteloo et al. (2011) [22] Netherlands 450 hospitals Retrospective and
prospective cohort
≥65 years 1222 2005–2010 Hip
Zhang et al. (2014) [52] USA State Inpatient
Database
Retrospective
cohort
Mean age > 65 27,017 2005–2010 Proximal
humerus
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations
Study Patient characteristics Association Clinical/service
characteristics
Association Percentage of
re-presentations
Readmissiona within 30 days
Readmission within 7 days from discharge
Tsai (2013) [47] Hospitalization for all
reasons
OR = 0.48 (0.32–0.72) Not investigated Hospitalization for
all reasons: 3.44 %
Fracture related
diagnoses
OR = 0.28 (0.12–0.68) Fracture related
diagnoses: 0.69 %
Musculoskeletal disorder OR = 0.08 (0.01–0.88) Musculoskeletal
disorders: 0.20 %
Hospitalization for other
diagnoses
OR = 0.67 (0.41–1.09) Hospitalization for other
diagnoses: 2.55 %
Readmission within 14 days from discharge
Jou et al.
(2014) [24]
14 days: 14 days: Medical
center
Referent 50–74 y (3.21 %)
Age < 75
Age ≥ 75
Referent
Regional hospital
District hospital
HR= 1.56 (1.08–2.25)HR = 1.36 (1.08–1.71)
HR = 4.47 (3.20–6.26)
14 days:
CCI score 0
CCI score≥ 2
LOS
≤10 days
≥11 days
≥75 y (4.16 %)
Referent Referent
HR = 1.52 (1.22–1.92) HR = 0.25 (0.19–0.34)
14 days: Geographic
regions
Northern
Central
Southern
Eastern
Referent
HR = 1.21 (0.89–1.64)
HR = 1.17 (0.89–1.54)
HR = 0.96 (0.47–1.96)
Readmission within 28 days from discharge
Khan et al.
(2012) [36]
Age OR = 1.06 (1.02–1.10) Not investigated 11 %
Diabetes OR = 3.34 (1.54–7.25)
History of neurological
disorders
OR = 5.66 (2.79–11.47)
Admission other than
home
OR = 2.36 (1.19–4.66)
Readmission within 30 days from discharge
Boddaert et al.
(2014) [21]
CIRS score RR = 1.08 (1.00–1.16) Intervention vs.
control group
RR= 0.40 (0.23–0.70) Orthopedic group
(usual care) = 17 %
Age RR = 0.99 (0.95–1.03) Geriatric group
(intervention) = 5 %
Male sex RR = 0.76 (0.41–1.41)
French et al.
(2008) [25]
Chronic heart failure OR = 1.24 (1.16–1.33) Inpatient LOS OR=1.01 (1.01–1.02) 18 %
Cardiac arrhythmias OR = 1.11 (1.04–1.17) 30 % occurred in the
first week
Other neurological
disorder
OR = 1.15 (1.05–1.26) 60 % within 2 weeks
Chronic pulmonary
disease
OR = 1.33 (1.25–1.40) 81 % within 3 weeks
Diabetes mellitus without
chronic
complication OR = 1.32 (1.15–1.52)
Renal failure OR = 1.43 (1.29–1.60)
Coagulopathy OR = 1.33 (1.16–1.52)
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations (Continued)
Weight loss OR = 1.24 (1.07–1.44)
Fluid and electrolyte
disorders
OR = 1.11 (1.04–1.20)
Deficiency anemia OR = 1.16 (1.09–1.25)
Alcohol abuse OR = 0.86 (0.75–0.98)
Psychosis OR = 1.16 (1.00–1.34)
Depression OR = 1.06 (0.95–1.18)
Heidari et al.
(2012) [26]
Not investigated Hospital drug policy
for chemical
thromboprophylaxis
55 %
Aspirin OR = 1.03 (0.87–1.23)
Heparin drug policy OR = 1.06 (0.97–1.16)
Low-dose heparin OR = 1.09 (0.93–1.28)
Jou et al.
(2014) [24]
30 days: 30 days: Medical
center
Referent 50–74 y (3.21 %)
≥75 y (4.87 %)
Age < 75
Age ≥ 75
Referent Regional hospital
District hospital
HR= 1.51 (1.10-2.09)
HR = 1.34 (1.07–1.62) HR = 3.82 (2.83–5.14)
30 days: LOS
CCI score 0
CCI score≥ 2
Referent ≤10 days
≥11 days
Referent
HR = 1.60 (1.30–1.97) HR = 0.32 (0.25–0.41)
30 days: Geographical
regions
Northern
Central
Southern
Eastern
Referent
HR = 1.25 (0.94–1.67)
HR = 1.20 (0.93–1.54)
HR = 1.00 (0.52–1.92)
Kates et al.
(2014) [28]
Age > 85 OR = 1.52 (1.02–2.26) Time to surgery
> 24 h
OR = 1.50 (1.00–2.25) 11 %
CCI ≥ 4 OR = 1.70 (1.02–2.81)
Delirium OR = 1.65 (1.13–2.40)
Dementia OR = 1.61 (1.12–2.33)
History of arrhythmia
with pacemaker
OR = 1.75 (1.11–2.76)
Placement presence of
a pre-op arrhythmia
OR = 1.62 (1.09–2.39)
Partial or complete
disability with ADL
OR = 1.54 (1.05–2.26)
Kates et al.
(2015) [49]
Age > 85 OR = 1.58 (1.02–2.26) Not investigated 11.9 %
Male OR = 1.49 (1.00–2.24)
Assisted living OR = 1.52 (0.82–2.59)
Skilled nursing OR = 1.24 (0.84–1.85)
Parker mobility medium
(5–8)
OR = 1.81 (0.98–3.35)
Parker mobility
low (0–4)
OR = 1.50 (0.85–2.64)
Charlson score
medium (2–3)
OR = 1.51 (1.03–2.25)
Charlson score high
(4 or more)
OR = 1.65 (1.00–2.74)
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations (Continued)
Partial or complete
disability
OR = 1.51 (1.03–2.25)
Delirium OR = 1.66 (1.14–2.41)
Preoperative arrhythmia OR = 1.62 (1.09–2.39)
Hematoma OR = 7.51 (0.47–1.21)
Urinary tract infection OR = 1.84 (0.39–8.84)
Pacemaker OR = 1.75 (1.11–2.76)
Diabetes OR = 1.91 (1.22–2.99)
Dementia OR = 1.61 (1.12–2.22)
GERD OR = 1.44 (0.99–2.10)
Cardiac disease OR = 1.02 (0.66–1.59)
Alcoholism OR = 1.12 (0.46–2.68)
Tobacco use OR = 0.99 (0.56–1.73)
Le-Wendling
et al. (2012)
[37]
Not investigated Local vs. general
anesthetic
OR = 2.0 (1.0-4.0) 19 %
Pollock et al.
(2015) [50]
Pre-existing pulmonary
disease
OR = 1.88 (1.30–2.72) Discharge to skilled
nursing facility
OR = 1.5 (1.04–2.14) 9 %
Hospital LOS
> 8 days
OR=1.88 (1.30–2.72)
Toson et al.
(2015) [53]
Myocardial infarction OR = 1.1 (1.0–1.2) Not investigated 16 %
Congestive heart failure OR = 1.2 (1.1–1.3)
Peripheral vascular
disease
OR = 1.2 (1.0–1.3)
Cerebrovascular accident OR = 1.1 (1.0–1.2)
Dementia OR = 0.8 (0.8–0.9)
Chronic pulmonary
disease
OR = 1.1 (1.0–1.2)
Connective tissue
disorder
OR = 1.2 (1.0–1.4)
Peptic ulcer OR = 1.2 (1.0–1.5)
Mild liver disease OR = 1.3 (1.0–1.7)
Diabetes without chronic
complications
OR = 1.1 (1.0–1.2)
Diabetes with chronic
complications
OR = 1.2 (1.1–1.3)
Hemiplegic or paraplegia OR = 0.9 (0.8–1.1)
Renal disease OR = 1.3 (1.2–1.5)
Any malignancy OR = 1.4 (1.2–1.6)
Metastatic solid tumor OR = 1.1 (0.9–1.4)
Moderate or severe liver
disease
OR = 5.0 (3.3–7.5)
Readmission within 30 days post-operative
Basques et al.
(2015) [30]
Age ≥ 90 OR = 1.35 (1.09–1.67) Discharge to a
facility
OR=1.42 (1.08–1.86) 10 %
Male OR = 1.40 (1.20–1.63) ASA class 3 OR=1.40 (1.09–1.69)
BMI≥ 35 OR = 1.73 (1.24–2.44) ASA class 4 OR=1.90 (1.44–2.51)
History of pulmonary
disease
OR = 1.46 (1.22–1.75)
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations (Continued)
Hypertension OR = 1.21 (1.02–1.45)
Steroid use OR = 1.38 (1.04–1.83)
Partially dependent
functional status
OR = 1.31 (1.11–1.54)
Fully dependent
functional status
OR = 1.41 (1.01–1.97)
Golinvaux
(2014) [48]
Non-insulin dependent
diabetes mellitus
Not investigated Without diabetes = 5 %,
Non-insulin dependent
diabetes mellitus = 7 %,
RR = 1.4 (1.0–2.0) Insulin dependent
diabetes mellitus = 7 %
Insulin-dependent
diabetes mellitus
RR = 1.4 (0.9–2.2)
Hageman et al.
(2014) [43]
CCI and age OR = 1.1, P < 0.01, R2 = 0.03 Not investigated 2 % readmitted without
surgical adverse event
4 % readmitted with
surgical adverse event
Ling et al.
(2013) [19]
Age 60–70 Referent Not investigated 9 %
Age 70–80 OR = 1.60 (0.31–8.22)
Age 80–90 OR = 3.91 (0.83–18.4)
Age > 90 OR = 7.21 (1.28–40.65)
Female Referent
Male OR = 0.75 (0.27–2.10)
Intertrochanteric OR = 0.84 (0.36–1.95)
Comorbidity = 0 Referent
Comorbidity > 1 OR = 0.73 (0.26–2.04)
Comorbidity > 2 OR = 0.48 (0.10–2.26)
Comorbidity > 3 OR = 1.53 (0.45–5.19)
Renal failure OR = 2.49 (0.50–12.4)
Serum albumin OR = 2.09 (0.69–6.36)
Serum iPTH OR = 1.01 (0.42–2.47)
Vitamin D deficiency OR = 1.00 (0.43–2.33)
Euthyroid Referent
Overt hypothyroidism OR = 1.75 (0.35–8.89)
Thyroid dysfunction OR = 1.19 (0.47–3.03)
Subclinical
hypothyroidism
OR = 0.44 (0.05–3.54)
Radcliff
(2008) [51]
White race OR = 1.32 Plate/screw
(CPT 27244)
OR = 1.26 7 %
Age 65–74 Referent Open reduction
(CPT 27236)
OR = 1.13
Age 75–84 OR = 1.17 Hemiarthroplasty
(CPT 27125)
OR = 1.30
Age ≥ 85 OR = 0.95 Percutaneous fixation
(CPT 27235)
OR = 1.05
Currently smoking OR = 0.94 Intramedullary implant
(CPT 27245)
OR = 0.92
Alcohol use
(>2 drinks/day)
OR = 1.29 General anesthesia OR = 0.97
Partial independence OR = 1.04 Blood transfusion
(1 U)
OR = 1.01
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations (Continued)
Total independence OR = 0.70 Surgery 4 days
after admission
OR = 0.70
Impaired sensorium OR = 1.67 Weekend surgery OR = 1.15
Renal insufficiency OR = 1.46 Wound not “clean” OR = 1.44
Steroid use OR = 1.10 Emergency admission OR = 0.74
Disseminated cancer OR = 0.87 ASA class 3 OR = 1.38
Congestive heart failure OR = 1.28 ASA class 4 or 5 OR = 1.60
Dementia OR = 0.75
Diabetes OR = 1.09
Hemiplegia OR = 1.02
Severe chronic obstructive
pulmonary disease
OR = 1.24
Recent weight loss OR = 0.99
Hyponatremia OR = 1.73
Toy et al.
(2014) [41]
History of pulmonary
disease
OR = 2.0 Inpatient status
before procedure
OR = 1.9 10.8 %
Tsai (2013) [47] Hospitalization for
all reasons
OR = 0.74 (0.59–0.93) Not investigated Hospitalization for all
reasons: 14.73 %
Fracture related
diagnoses
OR = 0.69 (0.45–1.05) Fracture-related
diagnoses: 3.73 %
Musculoskeletal
disorders
OR = 0.60 (0.37–0.98) Musculoskeletal
disorders: 2.36 %
Hospitalization for
other diagnoses
OR = 0.83 (0.62–1.12) Hospitalization for
other diagnoses: 9.23 %
Readmission to hospital within 30 days of admission to nursing home
Kiel et al.
(1994) [45]
Age 74–85 OR = 0.58 (0.40–0.83) Not investigated 12.4 %
Age > 85 OR = 0.55 (0.38–0.80)
Secondary neurological
diagnoses
OR = 0.75 (0.56–1.00)
Living with someone OR = 1.44 (1.12–1.87)
Any dependency
in ADLs
OR = 1.45 (1.08–1.93)
Ability to walk OR = 1.54 (1.16–2.05)
Readmission >30 days
Readmission to hospital within 60 days from discharge
Halm et al.
(2003) [27]
Active clinical issue in the
24 h before discharge
OR = 1.6 (1.0–2.6) Not investigated 18.8 %
New impairment in the
24 h before discharge
OR = 1.7 (1.2–2.3)
Halm et al.
(2003) [33]
Transfusion when Hb
< 10.0 g/dL
OR = 0.52 (0.28–0.97) 16.9 %
Halm et al.
(2004) [34]
Hb on admission OR = 0.69 (0.49–0.95) Not investigated 16.9 %
Hb lowest preoperative OR = 0.65 (0.48–0.89)
Hb lowest postoperative OR = 0.78 (0.64–0.95)
Readmission within 80 and 180 days
Ottenbacher et
al. (2003) [46]
Age Beta = 0.943, SEM = 0.374,
LR = 3.51
Not investigated 16.7 %
Ethnicity × gender Beta = 0.012, SEM = 0.005,
LR = 2.54
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations (Continued)
FIM rating Beta = −0.825, SEM = 0.293,
LR = 4.86
Readmission within 90 days from discharge
Vochteloo et
al. (2011) [22]
Age OR = 0.97 (0.94-0.99) ASA OR = 1.43 (0.99–2.09) Anemic group 12.9 %,
Non-anemic group 9.0 %
Anemia RR = 1.24 (1.04–1.49) General anesthesia OR = 0.35 (0.13–0.99)
Readmission 90 days from surgery
Zhang et al.
(2014) [52]
Male HR = 0.77 (0.72–0.83) Hemiarthroplasty HR = 0.77 (0.71–0.83) 90 day readmission
rate = 14 %
African-American race HR = 1.22 (1.02–1.46) RTSA HR = 0.82 (0.67–0.99) 15 % for open reduction-
internal fixation and RTSA
Medical comorbidities
(per diagnosis)
HR = 1.20 (1.18–1.22) 13 % for hemiarthroplasty
Insurance with Medicaid HR = 1.27 (1.08–1.49)
Private insurance HR = 0.82 (0.74–0.91)
Discharge status –
home with services
HR = 1.19 (1.07–1.32)
Transfer to facility
nursing or rehab
HR = 1.99 (0.82–2.18)
Gregersen et
al. (2011) [42]
Postop Hb levels
≤ 6 mmol/L
OR = 3.24 (1.15–9.14) Intervention care OR = 0.47 (0.23–0.94) 14 % intervention care
Age OR = 2.98 (1.08–8.21) 26 % standard care
Readmission within 180 days from surgery
Tsai (2013) [47] Hospitalization for
all reasons
OR = 0.93 (0.78–1.38) Not investigated Hospitalization for all
reasons: 38.31 %
Fracture related
diagnoses
OR = 0.90 (0.67–1.21) Fracture related
diagnoses: 9.14 %
Musculoskeletal
disorders
OR = 1.03 (0.77–1.38) Musculoskeletal
disorders: 9.43 %
Hospitalization for
other diagnoses
OR = 0.93 (0.77–1.13) Hospitalization for other
diagnoses: 26.72 %
Readmissions within 6 months from discharge
Härstedt et al.
(2015) [35]
Hypertension OR = 2.0 (1.2–1.9) Not investigated 32 %
Atrial Fibrillation OR = 0.80 (0.40–1.61) 73 % were admitted
once only
Myocardial infarction OR = 0.70 (0.30–1.64)
Angina pectoris OR = 0.49 (0.19–1.26)
Heart failure OR = 0.69 (0.29–1.61)
Pacemaker OR = 6.64 (1.68–26.33)
Valvular heart disease OR = 0.87 (0.17–4.60)
Syncope OR = 0.99 (0.36–2.71)
Stroke OR = 0.66 (0.31–1.40)
Pulmonary embolism/
deep vein thrombosis
OR = 2.72 (0.80–9.24)
Peripheral vascular
disease
OR = 1.01 (0.33–3.08)
Parkinson’s disease OR = 1.32 (0.32–5.70)
Epilepsy OR = 0.26 (0.03–2.15)
Cognitive disorder
(dementia)
OR = 1.68 (0.94–3.01)
Depression OR = 1.54 (0.63–3.78)
Diabetes mellitus OR = 0.64 (0.29–1.42)
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations (Continued)
Thyroid disease OR = 1.47 (0.70–3.12)
Respiratory disease
(COPD)
OR = 0.98 (0.42–2.26)
Malignancy OR = 1.16 (0.57–2.37)
Autoimmune disorders OR = 2.30 (0.87–6.10)
Prostate tumor (men) OR = 4.99 (0.92–27.18)
Previous fracture OR = 1.70 (0.86–3.36)
Osteoporosis OR = 0.30 (0.07–1.40)
Diseases in the kidney
and urinary
tract OR = 1.72 (0.57–5.16)
Anemia OR = 1.19 (0.43–3.32)
ASA classification per
one grade
OR = 1.67 (0.99–2.80)
Riggs et al.
(2010) [39]
Discharge to
rehabilitation
Standard coeff −0.095
(−0.102 to −0.11)
LOS 75th quartile
≥ 9 days)
Standard coefficient
0.151 (0.044–0.141)
8.3 %
Any days in
Intensive Care Unit
Standard coefficient
0.168 (0.097–0.271)
Readmission after 12 months from discharge
Bischoff-
Ferrari (2010)
[20]
2000- vs. 800-IU/d
dosage of
cholecalciferol
Relative rate
different, −39 %
(−62 % to −1 %)
70 % had 1 readmission,
22 % had 2 readmissions
and 7 % had 3
readmissions
Efficacy analysis:
2000 IU/d dose
Relative rate
different, −55 %
(−79 % to −2 %)
Giusti et al.
(2008) [32]
Age 76–85 OR = 0.77 (0.29–2.01) Not investigated 30.1 %
Age > 85 OR = 0.46 (0.16–1.29)
CIRS-SI 1.5–1.9 OR = 5.95 (1.66–21.3)
CIRS-SI > 1.9 OR = 7.05 (1.68–29.7)
2 month ADL Katz
Index 0–2
OR = 3.02 (1.09–8.32)
Heyes et al.
(2015) [29]
Female OR = 1.34 (0.65–2.76) Time to surgery
36 h to 6 days
OR = 1.62 (0.156–2.44) 44 %
Cephalomedullary nail OR = 1.51 (0.40–1.08) >6 days OR = 1.29 (0.198–3.02)
Hip hemiarthroplasty/
THR
OR = 3.10 (0.19–1.80) Inpatient stay
> 7 days
OR = 3.13 (0.12 –
0.62)
Moderate alcoholic OR = 1.36 (0.31–1.73) Inpatient stay of
7–14 days
OR= 7.04 (0.05 –
0.34)
Alcoholic OR = 1.52 (0.26–1.66) Inpatient stay of
14–21 days
OR= 2.90 (0.18 –
0.64)
Affected side-right OR = 1.10 (0.57–1.45) Inpatient stay of
21–28 days
OR = 1.83 (0.25–0.16)
Ex-smoker OR = 1.14 (0.64–2.00) Inpatient stay of
28–35 days
OR = 2.11 (0.19–1.17)
Smoker OR = 1.24 (0.56–2.72) ASA score > 2 OR = 3.68 (0.06–1.15)
Residential care/nursing
home residence
OR = 1.71 (1.34–1.98) ASA score > 3 OR = 1.95 (0.17–1.48)
ASA score > 4 OR = 2.14 (0.16–1.33)
Hb > 2 g/dL drop OR = 1.29 (0.48–1.24) Transfusion status
< 2 units
OR = 1.12 (0.31–4.00)
Admission glucose
> 7.8 mmol/L
OR = 1.18 (0.66–2.09) Transfusion status
> 2 units
OR = 1.85 (0.48–7.04)
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Table 3 Reported associations between patient or clinical characteristics with risk of hospital re-presentations (Continued)
Discharge glucose
> 7.8 mmol/L
OR = 1.05 (0.53–1.70)
Total protein OR = 1.13 (0.53–1.46)
Admission eGFR < 45 OR = 1.04 (0.50–1.83)
Discharge eGFR < 45 OR = 1.04 (0.47–1.96)
Hsaio et al.
(2011) [23]
Long-term use of
alendronate reduces
risk
HR = 0.27 (0.15–0.78) Not investigated 8.6 % cases untreated
cohort; 6.3 % alendronate
users; 7.6 % other anti
organophosphorous
drug users
Intrator et al.
(1998) [44]
Home healthcare
usage
OR = 0.77 (0.52–1.15) Not investigated Rehab only group 34.1 %
Rehab and home health
group 27.2 %
Jou et al.
(2014) [24]
1 year: 1 year: District
hospital
HR= 2.24 (1.82–2.75) 50–74 y (6.02 %)
Age < 75
Age ≥ 75
Referent LOS ≥75 y (8.38 %)
HR = 1.46 (1.24–1.73)
≤10 days
≥11 days
Referent
1 year: CCI = 0
CCI score≥ 2
Referent
HR = 0.51 (0.43–0.60)
HR = 1.28 (1.09–1.51)
1 year: Geographic
regions
Northern
Central
Southern
Eastern
Referent
HR = 1.12 (0.90–1.39)
HR = 1.07 (0.88–1.29)
HR = 0.89 (0.54–1.46)
Merchant
(2005) [38]
Post-operative
complications
After adjustment for potential
covariates the presence of
postoperative complications
was not significant (P > 0.05,
coefficients not presented)
Not investigated 31.7 %
Teixeira et al.
(2009) [40]
Male (predicts related
first readmission)
HR = 1.25 (1.08–1.46) Teaching hospital vs.
public hospital
(predicts related first
readmission)
32 %
Male HR = 1.36 (1.16–1.59) HR = 0.86 (0.79–0.95)
Increasing age
(predicts unrelated
first readmission)
HR = 0.94 (0.89–0.99) Index stay in a
private hospital
HR = 0.78 (0.67–0.9)
Cancer HR = 1.41 (1.03–1.94) Teaching hospital
(predicts unrelated
first readmission)
HR = 0.87 (0.79–0.95)
Kidney disease HR = 1.38 (1.00–1.90)
Dementia (predicts
related first readmission)
HR = 1.21 (1.01–1.46)
Dementia (predicts
unrelated first
readmission)
HR = 0.68 (0.53–0.87)
Readmission within 18 months from discharge
Fox et al.
(1998) [31]
Performance on
balance tests at 2
months post fracture
Beta = −0.155, P = 0.01
Gait score Beta = −0.013, P = 0.83
Mobility score Beta = −0.098, P = 0.11
CCI, Charlson comorbidity index; CIRS, Cumulative illness rating scale – severity index; ASA, American Society of Anesthesiologists score; LOS, length of stay;
ADL, activities of daily living; FIM, functional independence measure; CM, conservative treatment; RTSA, reverse total shoulder arthroplasty; Hb, hemoglobin;
HR, hazards ratio; OR, odds ratio; LR, likelihood ratio; RR, relative risk
aThe term readmission is being used as the studies have reported on hospital readmissions rather than hospital re-presentations
Bold text indicates a significant association (p <0.05)
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examined hemoglobin (Hb) reported a significant positive
association (Hb < 6 mmol/L) with hospital readmission
within 90 days [42]. One study identified cancer and de-
mentia as comorbidities at the index event to be predictive
of hospital readmission within a year [40]. One study
examined body mass index (BMI) and reported that pa-
tients with a BMI > 35 were at an elevated risk of being
readmitted to hospital after discharge [30]. Among the
cognitive disorders, dementia was the most common
comorbidity examined and was positively associated
with readmissions in three of the six studies in which it
was investigated [28, 40, 49].
In total, comorbidities were significant risk factors and
reasons for hospital readmission in 20 studies. The most
common comorbidities identified were myocardial in-
farction (n = 9) [25, 28, 35, 36, 40, 41, 48, 51, 53], pul-
monary embolism (n = 7) [25, 28, 39–41, 51, 53], urinary
tract infection (n = 6) [36, 38, 41, 48, 50, 51], pneumonia
(n = 9) [20, 29, 36, 38, 41, 42, 48, 50, 51], sepsis (n = 5)
[20, 36, 41, 48, 51], and renal failure (n = 4) [36, 41, 48, 53].
Other frequent reasons for readmission included surgical
complications (n = 6) [28, 40, 41, 43, 50, 52], re-fractures
(n = 5) [24, 28, 42, 50], and falls (n = 3) [35, 36, 38].
Other clinical and hospital indicators
A range of other clinical and hospital factors were exam-
ined. Length of stay in hospital served as a predictor of
re-presentation in six studies; of these, five studies
reported that a longer length of stay increased the risk of
subsequent hospital readmissions [24, 25, 29, 50]. An
American Society of Anesthesiologists (ASA) score > 3
was positively associated with risk of hospital readmission
[30] in one of the four studies in which it was investigated.
In another study, surgical delay of 24 hours or more was
associated with readmission [28]. One study observed that
older adults admitted into a geriatric unit managed by a
multidisciplinary team had lower risk of hospital readmis-
sion and improved walking ability [21].
Quality assessment
Findings from the quality assessment of the studies are
presented in Table 4. The global rating score for most
studies (n = 17; 48 %) was in the ‘moderate’ category.
However, the quality of 11 of the 35 studies (31 %) was
classified as ‘strong’. All 11 strong studies examined pa-
tients with hip fractures. Another seven studies (7 %),
which examined older adults with hip fractures, received
a score of ‘weak’. The weaknesses most frequently identi-
fied were a failure to report drop outs or withdrawals, a
lack of clear explanation about data collection processes,
and inadequate descriptions of how potential confounders
were controlled for.
Best-evidence synthesis
Eleven studies met the inclusion criteria for high quality
studies. In accordance with the global rating scale, these
studies had no ‘weak’ ratings in any sub-domain
(Table 4). Five of these studies (45 % of high quality
studies) reported at least one statistically significant risk
factor of hospital readmission that was identifiable at the
index admission [21, 27, 40, 42, 53]. Among the patient
factors associated with readmission in these five studies,
age was positively associated with hospital readmission
in one study [21]. One study each out of the 11 high
quality studies identified male sex, lower post-operative
Hb level, and higher CIRS score at index admission to
have positive associations with hospital re-presentations
[21, 40, 42]. Comorbidities that were significantly associ-
ated with hospital re-presentations in these studies in-
cluded impaired sensorium, renal insufficiencies, asthma,
chronic liver disease, dementia, cancer, ‘new impairments’
on discharge, adverse effects of glucocorticoids, and an-
drogen therapy [21, 27, 40, 42, 51]. In summary, of the 11
high quality studies (31 % of all included studies), five pro-
vided evidence of statistically significant findings, and the
correlates that were significant varied among studies.
Meta-analysis
The meta-analysis indicated age was associated with in-
creased risk of hospital readmission both within a 30-
day time-frame and beyond a 30-day time-frame (Fig. 2),
with the 95 % CIs of the pooled effect estimate not in-
clusive of 1.00. The random-effects pooled OR was 1.27
(95 % CI, 1.14–1.43) for the effect of age on the risk of
hospital readmission within 30 days (Fig. 2a). However, a
large amount of heterogeneity (I2 = 98 %) in study effect
size estimates was observed. The random-effects pooled
OR was 1.23 (95 % CI, 1.01–1.50) for the effect of age
on the risk of hospital readmission > 30 days (Fig. 2b).
The heterogeneity was also large (I2 = 94 %) among studies
reporting hospital readmission > 30 days. The sensitivity
analysis indicated that the removal of the small study [19]
with an outlying effect estimate had no difference on the
pooled effect estimate (Fig. 2c) and had a negligible effect
on overall heterogeneity (I2 = 97 %). It is noteworthy that
the calculations that were required to determine pooled
effect estimates from studies with disparate analysis and
reporting approaches resulted in pooled ORs that cannot
be interpreted as simple effects per increasing year of age.
However, the findings of an increasing risk with age, the
demonstrated significance at a 95 % CI, and the substantial
variation in reported effect among studies were note-
worthy findings from the meta-analysis.
Discussion
There are a number of useful inferences and research
priorities that can be drawn from the findings reported
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in this review. A key finding was that age was the most
frequently investigated risk factor for hospital readmis-
sion. The meta-analysis confirmed age as a predictor of
hospital re-presentations both within 30 days and for re-
presentations occurring after 30 days. Although age is
not modifiable, interventions that target high-risk older
adults before they leave hospital have been cost-effective
in reducing undesirable outcomes, and it has been sug-
gested that there may be some utility for these interven-
tions to be offered to older people recovering from fragility
fractures [54, 55]. An important consideration for future
research investigating age as a predictor of hospital re-
presentations may be to consider the linearity of the effect
of age on risk of re-presentation to hospital. The risk of re-
admission may not increase uniformly with increasing age
in years, but rather, there may be an accelerating increase
in risk of readmission with advancing age among people re-
covering from fragility fractures. However, further research
is required to confirm or refute this hypothesis in the con-
text of older adults recovering from fragility fractures.
Table 4 Quality assessment classifications from the Effective Public Health Practice Project Quality Assessment Tool
Lead author Year Selection bias Study design Confounder Blinding Data collection Dropouts & withdrawals Global rating
Basques 2015 [30] Moderate Moderate Moderate Moderate Strong Weak Moderate
Bischoff-Ferrari 2010 [20] Weak Strong Strong Strong Moderate Strong Strong
Boddaert 2014 [21] Moderate Moderate Strong Moderate Strong Strong Strong
Fox 1998 [31] Weak Moderate Weak Moderate Strong Weak Weak
French 2008 [25] Moderate Moderate Weak Moderate Strong Strong Moderate
Giusti 2008 [32] Strong Moderate Weak Moderate Strong Strong Moderate
Golinvaux 2014 [48] Moderate Moderate Strong Moderate Strong Strong Strong
Gregersen 2011 [42] Moderate Moderate Strong Moderate Strong Strong Strong
Hageman 2014 [43] Moderate Moderate Weak Moderate Strong Weak Weak
Halm 2003 [27] Strong Moderate Strong Moderate Strong Strong Strong
Halm 2003 [33] Strong Moderate Strong Moderate Strong Strong Strong
Halm 2004 [34] Strong Moderate Strong Moderate Strong Strong Strong
Härstedt 2015 [35] Strong Moderate Weak Moderate Strong Strong Moderate
Heyes 2015 [29] Moderate Moderate Weak Moderate Strong Moderate Moderate
Heidari 2012 [26] Moderate Moderate Strong Moderate Strong Weak Moderate
Hsaio 2011 [23] Moderate Moderate Strong Moderate Weak Weak Weak
Intrator 1998 [44] Weak Moderate Strong Moderate Strong Strong Weak
Jou 2014 [24] Moderate Moderate Strong Moderate Weak Weak Weak
Kates 2014 [28] Moderate Moderate Weak Moderate Strong Strong Moderate
Kates 2015 [49] Moderate Moderate Weak Moderate Strong Strong Moderate
Khan 2012 [36] Moderate Moderate Weak Moderate Strong Moderate Moderate
Kiel 1994 [45] Moderate Moderate Weak Moderate Strong Strong Moderate
Le-Wendling 2012 [37] Moderate Moderate Strong Moderate Weak Strong Moderate
Ling 2013 [19] Moderate Moderate Moderate Moderate Strong Weak Moderate
Merchant 2005 [38] Moderate Moderate Moderate Moderate Strong Strong Strong
Ottenbacher 2003 [46] Moderate Moderate Weak Moderate Strong Moderate Moderate
Pollock 2015 [50] Moderate Moderate Weak Moderate Strong Weak Weak
Radcliff 2008 [51] Moderate Moderate Strong Moderate Strong Strong Strong
Riggs 2010 [39] Moderate Moderate Moderate Moderate Strong Weak Moderate
Teixeira 2009 [40] Moderate Moderate Moderate Moderate Strong Strong Strong
Toson 2015 [53] Moderate Moderate Moderate Moderate Strong Moderate Strong
Toy 2014 [41] Moderate Moderate Weak Moderate Strong Strong Moderate
Tsai 2013 [47] Moderate Moderate Strong Moderate Weak Weak Moderate
Vochteloo 2011 [22] Moderate Moderate Strong Moderate Strong Weak Moderate
Zhang 2014 [52] Moderate Moderate Weak Moderate Moderate Weak Weak
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There was a high degree of variation (methodologies,
reporting quality, and results) across studies reporting
other potential risk factors. A salient finding from this
review was that studies with a high quality rating re-
ported the following factors, which were identified at
the index admission, to be significant predictors of re-
presentation to hospital: higher CIRS, ASA > 3, cardio-
vascular diseases, low post-operative Hb, kidney diseases,
dementia, and cancer [21, 27, 40, 42, 51]. Other potential
predictors identified from studies with a moderate quality
rating included anemia, neurological disorders, delirium,
renal failure, diabetes, longer length of stay, and being dis-
charged to a residential nursing care facility [22, 25, 28,
36]. Like age, many of these risk factors are likely to be dif-
ficult to modify in the context of clinical care during a
hospitalization. However, they may prove useful for guid-
ing the delivery of appropriate (and potentially targeted)
care models to offset this risk. Co-morbidities and length
of stay, which were reported as potential risk indicators in
the present review, are generally consistent with research
among other clinical populations [13, 56, 57]. This is a
useful finding, so far as it implies that interventions to re-
duce re-presentations that have been successful among
other clinical populations are worthy of consideration for
adaptation and evaluation, specifically among patients
with fragility fractures.
It was interesting to note that no factor that was inves-
tigated in multiple studies was consistently associated
with readmission in all studies in which it was investi-
gated. This observation of inconsistency among studies
for the same risk factor may seem innocuous, but in ac-
tuality highlights one of the key challenges in the field.
The inconsistency may be attributable to genuine vari-
ation in risk factors between populations and dissimilar
health services; however, it may be attributable to meth-
odological and reporting inconsistencies among studies
that may have contributed to seemingly incongruent
findings. This review has highlighted the extent of these
inconsistencies among studies in a systematic way for
the first time and should act as a call to reduce un-
necessary variation between health services and research
methodologies in this field.
Perhaps of even greater importance than potential in-
consistencies in findings was the gap in the literature
revealed in this systematic review. Specifically, a novel
finding was that no study was identified that had exam-
ined risk factors for re-presentation to ED without hospital
admission. Older adults disproportionately consume ED
resources and have been reported to account for 20 % of
presentations to EDs [58, 59]. This absence of studies
examining re-presentations to EDs without admission
to hospital by patients recovering from fragility fractures
Fig. 2 Forest plot of age as a predictor of hospital re-presentation within 30 days (a), after 30 days (b), and sensitivity analysis (c) (within 30 days)
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represents an important gap in the literature worthy of
further research to advance the field.
It was also notable that most of the 35 studies focused
on people treated for a hip fracture, including the eleven
studies with highest quality ratings [20, 21, 27, 33, 34,
38, 40, 42, 48, 51, 53]. Identifying the paucity of high
quality studies that have examined risk factors for re-
presentation to hospital following fragility fractures that
affect other important body regions (e.g., spine, shoulder,
pelvis (non-hip), ankle, wrist, and forearm) is another im-
portant finding from this review. Nonetheless, this review
has provided a consolidated synthesis of risk factors for
hospital re-presentations taking into account study quality
and consistency (and inconsistencies) among studies.
Strengths and limitations
A major strength of this review was that it used broad
search terms and multiple databases. A rigorous screen-
ing process was implemented, including two researchers
to independently conduct each stage of screening, data
extraction, and quality appraisal. The investigators also
considered it beneficial to have used the same quality
measurement tool that could be applied across a range
of study designs. This reduced the potential for quality
rating bias attributable to use of differing quality rating
instruments for different study designs. Along with the
aforementioned strengths were some notable limitations
of this review. First, the review was restricted to peer-
reviewed journal articles published in the English lan-
guage. Second, the inclusion of a range of study designs,
sample characteristics, and lengths of study enrolment
periods contributed to heterogeneity that prohibited the
valid pooling of data for meta-analyses for most potential
predictors. This was compounded by other methodo-
logical and reporting differences across studies.
Conclusions
There are several important recommendations for future
research following this investigation. First, further robust
examinations of risk factors for re-presentation to hospital
among patients who have sustained fragility fractures be-
yond those affected by hip fractures are warranted. Sec-
ond, investigation of risk factors for ED re-presentation
without admission are also worthy of investigation. Under-
standing risk factors for these re-presentations may inform
service enhancement to reduce the need for these patients
to present to a hospital ED. Third, investigations into how
specific elements of geriatric clinical care models poten-
tially related to risk of re-presentation can be optimized to
reduce risk would be beneficial. While some differences in
findings among studies may be attributable to study meth-
odology, it is likely that other discrepancies were due to
local clinical, patient, or environmental factors. A greater
understanding of the reasons for variations in risk factors
across geographical locations, services, and patient
samples may inform the development of interventions
or alternative models of care for improving patient care
and reducing risk.
A further pragmatic consideration is that the use of
emergency services and readmissions to hospitals other
than where the primary admission took place ought to
be considered wherever possible. Moreover, consistency
in the categorization of variables (e.g., age), definition of
the index event (e.g., date of discharge), and follow-up
periods (e.g. 30, 60, and 90 days) would be beneficial for
comparability across studies.
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